Strawberry notch homologue 2 regulates osteoclast fusion by enhancing the expression of DC-STAMP

The co-repressor Strawberry notch homolog 2 regulates DC-STAMP expression and osteoclast fusion, and its absence results in osteopetrosis.

[1]  S. Akira,et al.  TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis , 2009 .

[2]  Y. Kadono,et al.  Jun Dimerization Protein 2 (JDP2), a Member of the AP-1 Family of Transcription Factor, Mediates Osteoclast Differentiation Induced by RANKL , 2003, The Journal of experimental medicine.

[3]  Hiroshi Takayanagi,et al.  Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. , 2002, Developmental cell.

[4]  K. Matsuo,et al.  c-Fos-Deficient Mice Are Susceptible to Salmonella enterica Serovar Typhimurium Infection , 2006, Infection and Immunity.

[5]  S. Akira,et al.  Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. , 1999, Immunity.

[6]  K. Mikoshiba,et al.  Osteoblasts induce Ca2+ oscillation-independent NFATc1 activation during osteoclastogenesis , 2008, Proceedings of the National Academy of Sciences.

[7]  A. Leonardi,et al.  Requirement for NF-kappaB in osteoclast and B-cell development. , 1997, Genes & development.

[8]  Y. Toyama,et al.  DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells , 2005, The Journal of experimental medicine.

[9]  S. Akira,et al.  Cutting Edge: Preferentially the R-Stereoisomer of the Mycoplasmal Lipopeptide Macrophage-Activating Lipopeptide-2 Activates Immune Cells Through a Toll-Like Receptor 2- and MyD88-Dependent Signaling Pathway1 , 2000, The Journal of Immunology.

[10]  岩﨑 秀典.  The IκB Kinase Complex Regulates the Stability of Cytokine-Encoding mRNA Induced by TLR-IL-1R by Controlling Degradation of Regnase-1 , 2012 .

[11]  E. Wagner,et al.  Reaching a genetic and molecular understanding of skeletal development. , 2002, Developmental cell.

[12]  E. Wagner,et al.  c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. , 1994, Science.

[13]  J. Olerud,et al.  Methods to promote Notch signaling at the biomaterial interface and evaluation in a rafted organ culture model. , 2009, Journal of Biomedical Materials Research. Part A.

[14]  E. Schwarz,et al.  Regulation of human osteoclast development by dendritic cell‐specific transmembrane protein (DC‐STAMP) , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  K. Nakai,et al.  The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection , 2010, Nature Immunology.

[16]  Ulrich Siebenlist,et al.  Requirement for NF-κB in osteoclast and B-cell development , 1997 .

[17]  S. Akira,et al.  TANK is a negative regulator of Toll-like receptor signaling and critical for preventing autoimmune nephritis , 2009, Nature Immunology.

[18]  M. Soleimani,et al.  A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow , 2009, Nature Protocols.

[19]  J. Risteli,et al.  MT1-MMP is required for myeloid cell fusion via regulation of Rac1 signaling. , 2010, Developmental cell.

[20]  P. Pavasant,et al.  Surface-bound orientated Jagged-1 enhances osteogenic differentiation of human periodontal ligament-derived mesenchymal stem cells. , 2013, Journal of biomedical materials research. Part A.

[21]  D. Fisher,et al.  Linking osteopetrosis and pycnodysostosis: Regulation of cathepsin K expression by the microphthalmia transcription factor family , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A. Smith,et al.  Cutting edge: a transcriptional repressor and corepressor induced by the STAT3-regulated anti-inflammatory signaling pathway , 2008, The Journal of Immunology.

[23]  M. Drezner,et al.  Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  S. Akira,et al.  Cutting Edge: Role of Toll-Like Receptor 1 in Mediating Immune Response to Microbial Lipoproteins1 , 2002, The Journal of Immunology.

[25]  Peter J. Murray,et al.  Cutting Edge: A Transcriptional Repressor and Corepressor Induced by the STAT3-Regulated Anti-Inflammatory Signaling Pathway1 , 2007, The Journal of Immunology.

[26]  Osamu Takeuchi,et al.  The IκB kinase complex regulates the stability of cytokine-encoding mRNA induced by TLR–IL-1R by controlling degradation of regnase-1 , 2011, Nature Immunology.

[27]  J. Penninger,et al.  Receptor Activator of NF-κB Ligand and Osteoprotegerin Regulate Proinflammatory Cytokine Production in Mice1 , 2006, The Journal of Immunology.

[28]  D. Santosa,et al.  Mimicking cell-cell interactions at the biomaterial-cell interface for control of stem cell differentiation. , 2006, Journal of biomedical materials research. Part A.

[29]  S. Akira,et al.  The transcription factor Jdp2 controls bone homeostasis and antibacterial immunity by regulating osteoclast and neutrophil differentiation. , 2012, Immunity.

[30]  J. Lausen,et al.  Tal1 regulates osteoclast differentiation through suppression of the master regulator of cell fusion DC‐STAMP , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  S. Akira,et al.  TRAF Family Member-associated NF-κB Activator (TANK) Is a Negative Regulator of Osteoclastogenesis and Bone Formation* , 2012, The Journal of Biological Chemistry.

[32]  T. Tsukazaki,et al.  Critical Regulation of Bone Morphogenetic Protein-induced Osteoblastic Differentiation by Delta1/Jagged1-activated Notch1 Signaling* , 2005, Journal of Biological Chemistry.

[33]  T. Suda,et al.  Cell fusion in osteoclasts plays a critical role in controlling bone mass and osteoblastic activity. , 2008, Biochemical and biophysical research communications.

[34]  Osamu Takeuchi,et al.  Sequential control of Toll-like receptor–dependent responses by IRAK1 and IRAK2 , 2008, Nature Immunology.

[35]  S. Khosla.  Increasing options for the treatment of osteoporosis. , 2009, New England Journal of Medicine.

[36]  Y. Toyama,et al.  Induction of DC‐STAMP by Alternative Activation and Downstream Signaling Mechanisms , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[37]  S. Akira,et al.  Pathogen Recognition and Innate Immunity , 2006, Cell.